Association of heparin‐induced skin lesions, intracutaneous tests, and heparin‐induced IgG

Abstract

On the basis of the coincidence of local and systemic hyperreactivity to heparin and danaparoid, patients with heparin-induced skin lesions should receive r-hirudin, a nonheparin compound, for anticoagulant treatment.